Condition: High-risk Lung Resection Surgery · Sponsor: Hospices Civils de Lyon
High-risk patients scheduled for lung resection surgery are increasing and theoretically eligible to perioperative individualized goal-directed fluid therapy (GDFT). However, thoracic surgery is challenging for intraoperative stroke volume (SV) and/or cardiac output monitoring because it requires lateral positioning, one-lung ventilation, and open-chest condition. Pulse contour analysis and esophageal Doppler have been proposed with contrasting results, whereas dynamic indices have been shown useless for predicting fluid responsiveness in that specific setting. Besides, more invasive technologies like thermodilution are not routinely used at the bedside by careproviders. Chest bioreactance seems to be a feasible, safe, rustic, easy-to-use, and plug-and-play method to non-invasively and continuously monitor SV and cardiac output in thoracic cancer surgery patients, able to detect significant spontaneous and pharmacologically-induced changes over time. The impact of chest bioreactance on patients 'outcome remains however to be demonstrated. Indeed, the routine fluid management in patients undergoing lung resection surgery could be responsible of hypovolemia/hypoperfusion and/or hypervolemia/congestion leading to postoperative complications. The present national prospective multicenter randomized simple blind study aims to demonstrate that an individualized goal-directed fluid therapy (GDFT) driven by chest bioreactance improves outcomes within 30 days in lung resection surge…
This description comes directly from the study's public registry record.
FELLAHI Jean-Luc, M.D., Ph.D., · (+33) 4 72 11 89 33 · jean-luc.fellahi@chu-lyon.fr
SAMSON Géraldine · (+33) 4.27.85.53.26 · Geraldine.samson@chu-lyon.fr
Always discuss trial participation with your own doctor first.
| Hopital Louis Pradel | Bron, France | Recruiting |
| CHU Dijon Bourgogne | Dijon, France | Recruiting |
| Hôpital Arnaud de Villeneuve - CHU Montpellier | Montpellier, France | Recruiting |
| Chu Nancy | Nancy, France | Recruiting |
| Hôpital Européen Georges Pompidou | Paris, France | Recruiting |
| Hopital du Haut-Leveque - CHU Bordeaux | Pessac, France | Recruiting |
| CHU de Rennes | Rennes, France | Recruiting |
| CHU Nantes | Saint-Herblain, France | Recruiting |
| CHU Strasbourg | Strasbourg, France | Recruiting |
| Chu Toulouse | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06156943